Future studies should consider using the currently available array of iPSCs derived from patients with thyroid genetic conditions, including mutant THRB, THRA, and SLC16A2 (encoding MCT8) (79–82), to generate cortical organoids and explore mechanisms of thyroid hormone action in fetal cerebral cortex development. This evidence concerns the gene THRA and thyroid gland disorder.